Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters

Behavioural Brain Research

Volumn 198, Issue 2, 2009, Pages 440-448

  Gilbert, Jenifer ^a   Davis, Fred C ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cachexia; Circadian; EGF; Paraventricular nucleus; Suprachiasmatic; TGF

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FOOD INTAKE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; THALAMUS MIDLINE NUCLEUS; WEIGHT REDUCTION;

ANIMALS; CRICETINAE; EATING; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INFUSIONS, SUBCUTANEOUS; INJECTIONS, INTRAPERITONEAL; MALE; MESOCRICETUS; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; THIRD VENTRICLE; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; WEIGHT LOSS;

EID: 59649119755     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.11.046     Document Type: Article

References (50)

1. Aston-Jones G., Chen S., Zhu Y., and Oshinsky M.L. A neural circuit for circadian regulation of arousal. Nat Neurosci 4 (2001) 732-738
2. Chakrabarty S., Huang S., Moskal T.L., and Fritsche Jr. H.A. Elevated serum levels of transforming growth factor-alpha in breast cancer patients. Cancer Lett 79 (1994) 157-160
3. Cheng M.Y., Bullock C.M., Li C., Lee A.G., Bermak J.C., Belluzzi J., et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417 (2002) 405-410
4. Chou T.C., Scammell T.E., Gooley J.J., Gaus S.E., Saper C.B., and Lu J. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci 23 (2003) 10691-10702
5. Cleeland C.S., Bennett G.J., Dantzer R., Dougherty P.M., Dunn A.J., Meyers C.A., et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97 (2003) 2919-2925
6. Coogan A.N., and Piggins H.D. Circadian and photic regulation of phosphorylation of ERK1/2 and Elk-1 in the suprachiasmatic nuclei of the Syrian hamster. J Neurosci 23 (2003) 3085-3093
7. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933 (2001) 222-234
8. de la Iglesia H.O., and Meyer JSchwartz W.J. Lateralization of circadian pacemaker output: Activation of left- and right-sided luteinizing hormone-releasing hormone neurons involves a neural rather than a humoral pathway. J Neurosci 23 (2003) 7412-7414
9. Elmquist J.K., Scammell T.E., Jacobson C.D., and Saper C.B. Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J Comp Neurol 371 (1996) 85-103
10. Ferrer I., Alcantara S., Ballabriga J., Olive M., Blanco R., Rivera R., et al. Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain. Prog Neurobiol 49 (1996) 99-123
11. Hao H., and Schwaber J. Epidermal growth factor receptor induced Erk phosphorylation in the suprachiasmatic nucleus. Brain Res 1088 (2006) 45-48
12. Italiano A. Targeting the epidermal growth factor receptor in colorectal cancer: advances and controversies. Oncology 70 (2006) 161-167
13. Jobst E.E., Robinson D.W., and Allen C.N. Potential pathways for intercellular communication within the calbindin subnucleus of the hamster suprachiasmatic nucleus. Neuroscience 123 (2004) 87-99
14. Junier M.P. What role(s) for TGFalpha in the central nervous system?. Prog Neurobiol 62 (2000) 443-473
15. Kalsbeek A., and Buijs R.M. Output pathways of the mammalian suprachiasmatic nucleus: coding circadian time by transmitter selection and specific targeting. Cell Tissue Res 309 (2002) 109-118
16. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., et al. Cytokine-induced sickness behavior. Brain Behav Immun 17 Suppl. 1 (2003) S112-S118
17. Klein D.C., Moore R.Y., and Reppert S.M. Suprachiasmatic nucleus: the mind's clock (1991), Oxford University Press, New York
18. Kramer A., Yang F.C., Snodgrass P., Li X., Scammell T.E., Davis F.C., et al. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 294 (2001) 2511-2515
19. Kraves S., and Weitz C.J. A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor activity. Nat Neurosci 9 (2006) 212-219
20. Kriegsfeld L.J., Leak R.K., Yackulic C.B., LeSauter J., and Silver R. Organization of suprachiasmatic nucleus projections in Syrian hamsters (Mesocricetus auratus): an anterograde and retrograde analysis. J Comp Neurol 468 (2004) 361-379
21. Leak R.K., and Moore R.Y. Topographic organization of suprachiasmatic nucleus projection neurons. J Comp Neurol 433 (2001) 312-334
22. Lehman M.N., Silver R., Gladstone W.R., Kahn R.M., Gibson M., and Bittman E.L. Circadian rhythmicity restored by neural transplant. Immunocytochemical characterization of the graft and its integration with the host brain. J Neurosci 7 (1987) 1626-1638
23. Li X., Sankrithi N., and Davis F.C. Transforming growth factor-alpha is expressed in astrocytes of the suprachiasmatic nucleus in hamster: role of glial cells in circadian clocks. Neuroreport 13 (2002) 2143-2147
24. Lindley J., Deurveilher S., Rusak B., and Semba K. Transforming growth factor-alpha and glial fibrillary acidic protein in the hamster circadian system: daily profile and cellular localization. Brain Res 1197 (2008) 94-105
25. Ma Y.J., Costa M.E., and Ojeda S.R. Developmental expression of the genes encoding transforming growth factor alpha and its receptor in the hypothalamus of female rhesus macaques. Neuroendocrinology 60 (1994) 346-359
26. Ma Y.J., Hill D.F., Junier M.P., Costa M.E., Felder S.E., and Ojeda S.R. Expression of epidermal growth factor receptor changes in the hypothalamus during the onset of female puberty. Mol Cell Neurosci 5 (1994) 246-262
27. Ma Y.J., Junier M.P., Costa M.E., and Ojeda S.R. Transforming growth factor-alpha gene expression in the hypothalamus is developmentally regulated and linked to sexual maturation. Neuron 9 (1992) 657-670
28. Moore R.Y. Neural control of the pineal gland. Behav Brain Res 73 (1996) 125-130
29. Mrosovsky N., Redlin U., Roberts R.B., and Threadgill D.W. Masking in waved-2 mice: EGF receptor control of locomotion questioned. Chronobiol Int 22 (2005) 963-974
30. Obrietan K., Impey S., and Storm D.R. Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci 1 (1998) 693-700
31. Pan W., and Kastin A.J. Entry of EGF into brain is rapid and saturable. Peptides 20 (1999) 1091-1098
32. Pan W., Vallance K., and Kastin A.J. TGFalpha and the blood-brain barrier: accumulation in cerebral vasculature. Exp Neurol 160 (1999) 454-459
33. Plata-Salaman C.R. Food intake suppression by growth factors and platelet peptides by direct action in the central nervous system. Neurosci Lett 94 (1988) 161-166
34. Plata-Salaman C.R. Epidermal growth factor and the nervous system. Peptides 12 (1991) 653-663
35. Ralph M.R., Foster R.G., Davis F.C., and Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 247 (1990) 975-978
36. Rich T., Innominato P.F., Boerner J., Mormont M.C., Iacobelli S., Baron B., et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 11 (2005) 1757-1764
37. Rich T.A. Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J Support Oncol 5 (2007) 167-174 [discussion 176-7]
38. Rivest S., Lacroix S., Vallieres L., Nadeau S., Zhang J., and Laflamme N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med 223 (2000) 22-38
39. Saper C.B., Lu J., Chou T.C., and Gooley J. The hypothalamic integrator for circadian rhythms. Trends Neurosci 28 (2005) 152-157
40. Schwartz W.J., and Reppert S.M. Neural regulation of the circadian vasopressin rhythm in cerebrospinal fluid: a pre-eminent role for the suprachiasmatic nuclei. J Neurosci 5 (1985) 2771-2778
41. Silver R., LeSauter J., Tresco P.A., and Lehman M.N. A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 382 (1996) 810-813
42. Snodgrass-Belt P., Gilbert J.L., and Davis F.C. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters. Brain Res 1038 (2005) 171-182
43. Tang P., Steck P.A., and Yung W.K. The autocrine loop of TGF-alpha/EGFR and brain tumors. J Neurooncol 35 (1997) 303-314
44. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2 (2002) 862-871
45. Tournier B.B., Dardente H., Vuillez P., Pevet P., and Challet E. Expression of Tgfalpha in the suprachiasmatic nuclei of nocturnal and diurnal rodents. Neuroscience (2007)
46. Van Setten G.B., Edstrom L., Stibler H., Rasmussen S., and Schultz G. Levels of transforming growth factor alpha (TGF-alpha) in human cerebrospinal fluid. Int J Dev Neurosci 17 (1999) 131-134
47. Vogelbaum M.A., and Menaker M. Temporal chimeras produced by hypothalamic transplants. J Neurosci 12 (1992) 3619-3627
48. Watts A.G., and Swanson L.W. Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of flourescent dyes and simultaneous peptide immunohistochemistry in the rat. J Comp Neurol 258 (1987) 230-252
49. Xian C.J., and Zhou X.F. Roles of transforming growth factor-alpha and related molecules in the nervous system. Mol Neurobiol 20 (1999) 157-183
50. Yarden Y. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur J Cancer 37 Suppl. 4 (2001) S3-8